Collectively, these findings highlighted the promising prospects of a dual blockade strategy targeting CD47/SIRPα and PD-1/PD-L1, in combination with radiotherapy, as an effective approach for achieving optimal tumor elimination. The gene discussed is CD47; the disease is neoplasm.